Dynamic Business Logo
Home Button
Bookmark Button
NSW moves up the date to ease restrictions for the vaccinated after higher-than-expected vaccine rate

Image credit: Spencer Davis

Government secures 25m Moderna doses in bid to diversify vaccine portfolio

The federal government has snapped up 25 million doses of the Moderna COVID-19 vaccine as part of its strategy to give Australians access to a booster or variant vaccine.

The government said the US-based Moderna vaccine will provide more flexibility for the national vaccine rollout and secure early access to possible vaccinations for emerging COVID-19 variants.

As highlighted in the 2021-22 Budget, the government is also set to commence its approach to market for mRNA manufacturing capacity and is in talks with Moderna regarding the establishment of an onshore manufacturing facility.

The government’s official release says local manufacture would ensure a long-term supply of Moderna’s mRNA-based vaccines against COVID-19, including variants, and for potential future pandemics.

“This is the second messenger RNA (mRNA) vaccine to be purchased by the government, providing access to the current Moderna vaccine or variant-specific versions of the vaccine developed by Moderna, to address longer term immunity or emerging viral variants in the first half of 2022,” it reads.

“To date, the Moderna vaccine has shown an overall vaccine efficacy against symptomatic COVID-19 of 94.1 per cent, and 100 per cent efficacy against severe COVID-19. It has also shown strong protection of 90 per cent efficacy against COVID-19 for at least six months after the second dose.”

Regulatory authorities that have approved and are using the Moderna vaccine so far include those in the European Union, the United Kingdom, the United States, Canada, and Singapore.

Also read: Budget 2021’s patent box scheme to boost Australian medical & biotech innovations, but is it too limited?

In order for supply to commence in Australia, the vaccine will first need to be approved as safe and effective by the Therapeutic Goods Administration (TGA). The government said it expects an application by Moderna to the TGA “shortly,” although it has not given any further information at this stage.

Australia currently has five agreements to secure more than 195 million doses of COVID-19 vaccines if they are shown to be safe and effective. Around $6 billion has been invested to support the COVID-19 vaccine roll-out.

Keep up to date with our stories on LinkedInTwitterFacebook and Instagram.

What do you think?

    Be the first to comment

Add a new comment

Dahlia Jovic

Dahlia Jovic

Dahlia is a Junior Editor and Journalist at Dynamic Business. She is an Honours student in Media and Communications at the University of Sydney with a specialisation in Digital Cultures. Her areas of interest include business, technology, entertainment and videography.

View all posts